BiopharmaTrend.com

Caribou Biosciences

Caribou Biosciences

Private company
CARIBOU BIOSCIENCES

Caribou Biosciences is a pioneer in the revolutionary field of CRISPR-Cas genome editing. Our proprietary technology puts us at the forefront of the development of new medical therapies and bio-based products which offer profound benefits to both human health and society as a whole.


Founded
2011
Status
Private company
Geography
United States of America based
Funding
$74.600 M
Patents
22
Research papers
8

Products

No products posted yet

Services

No services posted yet


This service is currently only supported on the desktop screens, please, use this service from your desktop or laptop for correct visualization and functionality

Go to home page